VC Daily: Expansion Therapeutics Gets $80 Million for RNA-Targeted Drugs morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Imara to Present Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association (EHA) Annual Congress - read this article along with other careers information, tips and advice on BioSpace
Life of Young Mom with Sickle Cell Disease Improved by New Drug
Patients at UConn Health s New England Sickle Cell Institute have a range of advanced health management options available to them
Brandy Compton, with her son Jermaine (contributed photo). Copy Link
Since she was only 4 months old, Brandy Compton, 31, of Hartford, has been battling sickle cell disease, a painful inherited red blood cell condition impacting the blood’s circulation due to abnormally hook-shaped red blood cells.
“As a baby I wouldn’t stop crying, and nothing my mother did worked to console me. Then they found out I had sickle cell disease,” says Compton. “Growing up was challenging, and I was homeschooled after the third grade since I was missing way too many days of school due to my painful disease.”
New Oxbryta, taking place online June 9-17, 2021. Results from an analysis of the Phase 2a HOPE-KIDS 1 Study (GBT440-007) in children with SCD ages 4 to 11 years treated with Oxbryta (voxelotor) tablets